SE456135B - Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav - Google Patents

Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav

Info

Publication number
SE456135B
SE456135B SE8305535A SE8305535A SE456135B SE 456135 B SE456135 B SE 456135B SE 8305535 A SE8305535 A SE 8305535A SE 8305535 A SE8305535 A SE 8305535A SE 456135 B SE456135 B SE 456135B
Authority
SE
Sweden
Prior art keywords
preparation
carrier material
composition according
polymeric carrier
modified
Prior art date
Application number
SE8305535A
Other languages
English (en)
Swedish (sv)
Other versions
SE8305535D0 (sv
SE8305535L (sv
Inventor
V I Talapin
E A Rimzha
F N Kaputsky
V A Stelmakh
G V Ustichenko
T L Jurkshtovich
Original Assignee
Bruss Ni Sanitarno Gigieniches
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruss Ni Sanitarno Gigieniches filed Critical Bruss Ni Sanitarno Gigieniches
Publication of SE8305535D0 publication Critical patent/SE8305535D0/xx
Publication of SE8305535L publication Critical patent/SE8305535L/
Publication of SE456135B publication Critical patent/SE456135B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/16—Two dimensionally sectional layer
    • Y10T428/163—Next to unitary web or sheet of equal or greater extent
    • Y10T428/164—Continuous two dimensionally sectional layer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24802—Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.]
    • Y10T428/2481—Discontinuous or differential coating, impregnation or bond [e.g., artwork, printing, retouched photograph, etc.] including layer of mechanically interengaged strands, strand-portions or strand-like strips
    • Y10T428/24818—Knitted, with particular or differential bond sites or intersections

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8305535A 1982-02-22 1983-10-07 Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav SE456135B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SU3425002 1982-02-22
SU3425001 1982-03-16
SU3470509 1982-06-07

Publications (3)

Publication Number Publication Date
SE8305535D0 SE8305535D0 (sv) 1983-10-07
SE8305535L SE8305535L (sv) 1983-10-07
SE456135B true SE456135B (sv) 1988-09-12

Family

ID=27356396

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8305535A SE456135B (sv) 1982-02-22 1983-10-07 Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav

Country Status (7)

Country Link
US (1) US4971079A (de)
JP (1) JPS59500217A (de)
CH (1) CH658594A5 (de)
DE (1) DE3332429T1 (de)
GB (1) GB2125699B (de)
SE (1) SE456135B (de)
WO (1) WO1983002892A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317576D0 (en) * 1983-06-29 1983-08-03 Shaw A S W Consumer tobacco products
JO1560B1 (en) * 1989-01-21 1991-11-27 الشركة العربية لصناعة الأدوية المساهمة المحدودة Mouthwash to prevent smoking
US5488962A (en) * 1990-10-10 1996-02-06 Perfetti, S.P.A. Chewing gum which is a substitute for tobacco smoke
AU9138891A (en) * 1990-12-14 1992-07-08 Steven J. Mondre Nicotine-containing dental floss
US5414005A (en) * 1993-10-28 1995-05-09 Dynagen, Inc. Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
TW261531B (de) * 1993-10-28 1995-11-01 Dynagen Inc
US5666979A (en) * 1994-09-29 1997-09-16 Chase; Gene Cigar substitute
US5875786A (en) * 1994-09-29 1999-03-02 Chase; Gene Cigar substitute
US5662919A (en) * 1994-11-21 1997-09-02 Alcon Laboratories, Inc. Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds
EP0937077B1 (de) 1996-10-30 2006-05-17 Pfizer Inc. Pyridon-kondensierte azabicyclische- oder cytisin-derivate, ihre herstellung und verwendung in der suchttherapie
US6949264B1 (en) 1996-11-27 2005-09-27 Wm. Wrigley Jr. Company Nutraceuticals or nutritional supplements and method of making
US6087376A (en) * 1997-02-05 2000-07-11 University Of Kentucky Research Foundation Use of lobeline compounds in the treatment of central nervous system diseases and pathologies
US5830904A (en) * 1997-02-05 1998-11-03 University Of Kentucky Research Foundation Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders
AUPO897997A0 (en) * 1997-09-04 1997-09-25 King, Michael Glenn Improved compositions and methods for the control of smoking
ES2141024B1 (es) * 1997-10-03 2000-10-16 Manzanares Jesus Mari Gonzalez Preparado de accion antinicotinica.
WO2000004882A1 (en) * 1998-07-21 2000-02-03 Alpenstock Holdings Limited Formulations of anionic polysaccharides
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US7935362B2 (en) 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
US6322828B1 (en) 1999-09-13 2001-11-27 Deseret Laboratories, Inc. Process for manufacturing a pharmaceutical chewing gum
WO2001021147A1 (en) 1999-09-20 2001-03-29 Mastercare Diet and weight control gum and sucker
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
WO2001089476A1 (en) * 2000-05-19 2001-11-29 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US6534527B2 (en) 2000-06-02 2003-03-18 Phytos, Inc. Edible herbal compositions for relieving nicotine craving
US7115288B2 (en) 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
DE10037983B4 (de) * 2000-08-03 2006-04-13 Stefan Zikeli Polymerzusammensetzung und daraus hergestellter Formkörper mit einem Gehalt an Alkaloid
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
WO2004056363A2 (en) 2002-12-20 2004-07-08 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
WO2005046363A2 (en) 2003-11-07 2005-05-26 U.S. Smokeless Tobacco Company Tobacco compositions
US20050234024A1 (en) * 2004-04-14 2005-10-20 Clarke David E Materials and methods for the treatment of ulcerative colitis
US20060211649A1 (en) * 2005-03-21 2006-09-21 Eric Marchewitz Use of cytisine for enhancing physical performance
WO2007041035A2 (en) * 2005-09-30 2007-04-12 Wm. Wrigley Jr. Company Oral composition and method for stress reduction associated with smoking cessation
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US8506936B2 (en) * 2008-11-25 2013-08-13 Watson Laboratories, Inc. Stabilized nicotine chewing gum
CN106390128B (zh) 2011-01-10 2022-07-08 伊沃恩有限公司 β-肾上腺素能反向激动剂用于戒烟的用途
US20160199315A1 (en) * 2013-08-23 2016-07-14 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
PL408608A1 (pl) 2014-06-18 2015-12-21 Pharmacia Polonica Spółka Z Ograniczoną Odpowiedzialnością Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania
EP3598968A1 (de) * 2018-07-23 2020-01-29 Adamed Pharma S.A. Feste pharmazeutische cytisin-zusammensetzung
CA3153405A1 (en) 2019-09-12 2021-03-18 Achieve Life Sciences, Inc. Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL255047A (de) * 1959-08-21
FR4627M (de) * 1965-05-14 1966-11-28
NL167303C (nl) * 1970-07-22 Leo Ab Vormstukken van kauwgom, bestaande uit een kauwgomba- sismassa, een tabaksalkaloide en eventueel andere ge- bruikelijke bestanddelen van kauwgom.
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
JPS5716773B2 (de) * 1974-05-17 1982-04-07
CA1087905A (en) * 1976-02-02 1980-10-21 Donald A.M. Mackay Long-lasting flavored chewing gum including chalk- free gum base
US4151270A (en) * 1977-09-26 1979-04-24 Wm. Wrigley Jr. Company Chewing gum composition
US4195645A (en) * 1978-03-13 1980-04-01 Celanese Corporation Tobacco-substitute smoking material
US4276890A (en) * 1979-04-11 1981-07-07 Fichera Anthony T Tobacco smoking inhibitor

Also Published As

Publication number Publication date
DE3332429T1 (de) 1984-01-26
WO1983002892A1 (en) 1983-09-01
SE8305535D0 (sv) 1983-10-07
GB2125699A (en) 1984-03-14
US4971079A (en) 1990-11-20
CH658594A5 (de) 1986-11-28
JPS59500217A (ja) 1984-02-16
SE8305535L (sv) 1983-10-07
GB8327748D0 (en) 1983-11-16
GB2125699B (en) 1986-02-12

Similar Documents

Publication Publication Date Title
SE456135B (sv) Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav
DE69610323T2 (de) Sich schnell im munde auflösende zusammensetzungen für dopaminagonisten
US3870794A (en) Treatment of certain emotional disorders with nicotine compounds
JPH04501425A (ja) ロラタジン、イブプロフェンおよびプソイドエフェドリンを含む薬剤組成物
JPS591412A (ja) 脳血管不全症処置用固形製剤
WO2003018015A1 (de) Elektronischer baustein
SK20099A3 (en) Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
HU229565B1 (hu) Buprenorfin tartalmú, fájdalomcsillapító hatású gyógyszerkészítmények
RU2002106399A (ru) Составы моксифлоксацина, содержащие поваренную соль
JPH11501282A (ja) コリン受容体作用薬及び拮抗薬としてのエピバチジン及びその誘導体
AU693144B2 (en) Taste masked composition containing a drug/polymer complex
JPS5874608A (ja) アヘン製剤に関して末梢「きつ」抗作用を有する製薬組成物
JPH0729916B2 (ja) 鎮痛性を有する医薬組成物
Furtado et al. Development and characterization of orodispersible tablets of famotidine containing a subliming agent
RU2261098C2 (ru) Перорально распадающаяся композиция, содержащая миртазапин
JPH037223A (ja) 吸入用喘息治療剤
IE85899B1 (en) New oral drug forms
US3359166A (en) Method of effecting analgesia
WO1995007282A1 (fr) Antidepresseur
JP2003503459A (ja) パラセタモール及びブスピロンを含有した鎮痛性作用を有する新規医薬組成物
DE2605243A1 (de) Pyrazolessigsaeurehaltiges arzneimittel
JP2001511159A (ja) オキシムを含むシナプス機能障害の処置用医薬組成物
JPH0232020A (ja) モルフィン鎮痛治療における耐性発現の抑制方法および薬剤
AU1045695A (en) Use of lobeline for the treatment of nicotine withdrawal
CS199202B2 (en) Method of producing gelatine capsules to be bitten up

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8305535-0

Effective date: 19940910

Format of ref document f/p: F